Tauklarify is a radioactive tracer injected before a PET scan, allowing deposits of tau protein in the brain to be visualised in adults with cognitive impairment who are being evaluated for Alzheimer’s disease.
The approval is based on two studies in which independent reviewers assessed PET scans from more than 500 participants.